Hviid Ulla, Hviid Thomas Vauvert F, Rudnicki Martin
Department of Obstetrics and Gynaecology, Roskilde University Hospital, Roskilde, Denmark.
Int Urogynecol J. 2010 May;21(5):529-34. doi: 10.1007/s00192-009-1018-3. Epub 2010 Feb 18.
The effect of a Pelvicol graft compared with a conventional anterior vaginal repair was evaluated in this randomised controlled study.
Only patients with a stage II or higher (Ba >or= -1) defect were included.
Thirty-one patients were allocated to a conventional anterior repair; 30 to Pelvicol graft. At 12 months follow-up, four patients among controls (15%) and two in the graft group (7%) had objective recurrence. Among controls, the difference at 3 months follow-up in Ba was 6.0 cm when compared with the position of Ba prior to surgery. In the graft group, the difference was 7.0 cm (P < 0.05). This difference was still present at 12 months follow-up (6.0 vs. 7.0 cm; P < 0.05).
The implantation of a Pelvicol graft does not improve the POP-Q stage.
在这项随机对照研究中,评估了Pelvicol移植物与传统阴道前壁修补术相比的效果。
仅纳入II期或更高分期(Ba≥ -1)缺损的患者。
31例患者被分配至传统阴道前壁修补组;30例被分配至Pelvicol移植物组。在12个月的随访中,对照组中有4例患者(15%)出现客观复发,移植物组中有2例(7%)。在对照组中,与术前Ba的位置相比,3个月随访时Ba的差异为6.0厘米。在移植物组中,差异为7.0厘米(P<0.05)。在12个月的随访中,这种差异仍然存在(6.0对7.0厘米;P<0.05)。
植入Pelvicol移植物并不能改善盆腔器官脱垂定量分期(POP-Q分期)。